Most developing structures that express the transcription factor gene AP-2a are compromised in AP-2a mutant mouse embryos. Since the cardiac neural crest population is one prominent site of AP-2a expression, and because the neural crest is known to be required for normal cardiac morphogenesis, we have investigated the involvement of AP-2a in cardiac development. All AP-2a-deficient embryos examined had malformations of the outflow tract of the developing heart: most had double outlet right ventricle, and a small fraction had persistent truncus arteriosus. To visualize AP-2a-expressing cells during the period of cardiac morphogenesis, we established a new mutant germline allele in which an IRES-lacZ sequence was inserted by homologous recombination into the AP-2a locus. Positive expression was observed in the cardiac neural crest population during the E9.5-10.5 period (as well as in other known domains of AP-2a expression previously noted by in situ hybridization studies), and was mostly extinguished by E11.5 when the cardiac neural crest has migrated into the outflow tract of the developing heart. Importantly, the distribution of AP-2a-expressing cardiac neural crest appeared to be identical in normal and mutant embryos. From this analysis, we propose that the AP-2a gene functions within the neural crest lineage, that AP-2a is not required for neural crest cell migration, and that normal AP-2a gene function is required prior to E11.5. AP-2a may be involved in an interaction between neural crest and surrounding tissues in the subpharyngeal region, thereby promoting normal outflow tract morphogenesis. q
Introduction
AP-2a is the founding member of the helix-span-helix family of transcription factors that in mammals also includes the AP-2b and AP-2g genes (Bosher et al., 1995; Chazaud et al., 1996; Imagawa et al., 1987; Mitchell et al., 1987; Moser et al., 1995; Williams et al., 1988) . The AP-2a gene was originally isolated using a biochemical purification procedure from HeLa cells (Mitchell et al., 1987) , and further studies have shown that it is expressed in several other adult tumor cell types, including breast cancers and melanomas (Bar-Eli, 1999; Bosher et al., 1996) . In situ hybridization studies in the mouse have demonstrated that AP-2a is prominently expressed in the developing embryo (Mitchell et al., 1991) . Major sites of expression include the neural tube and the migratory neural crest at cranial (preotic and postotic hindbrain) and cervical levels. Additional domains of expression include the progress zone of the limb bud, the developing kidney, the eye, and surface ectoderm. AP-2a gene function is required for the normal differentiation of most, if not all, of these structures, in that deficiency of AP-2a results in defects in neural tube closure, body wall closure and associated thoracic organization, eye development, and limb morphogenesis (Nottoli et al., 1998; Schorle et al., 1996; West-Mays et al., 1999; Zhang et al., 1996) . Moreover, defects are observed in several neural crest-derived structures, particularly in the craniofacial skeleton and the cranial ganglia. Despite the severity of these defects, AP-2a 2/2 embryos are generally viable to full term.
Given the importance of AP-2a for the development of cranial structures derived from the neural crest, in this study, we have investigated the function of AP-2a in cardiac morphogenesis, a process that requires a contribution from a more caudal neural crest cell population. In normal cardiac development (reviewed in Harvey and Rosenthal, 1998) , the early heart is organized with a single ventricular chamber and a single outflow tract (here broadly defined to include the conotruncus and the aortic sac). Bilaterally paired aortic (pharyngeal) arch arteries connect the outflow tract to the dorsal aortae and general circulation. In the mouse embryo, septation of the ventricle into left and right chambers, and septation of the outflow tract into distinct aortic and pulmonary outflow channels, occurs during the E10.5-13.5 period. Although these represent several distinct and genetically separable processes, their spatial and temporal coordination is necessary in order to properly align the ascending aorta with the left ventricle, and the pulmonary trunk with the right ventricle. Concurrent with these events, the pharyngeal arch arteries also become reorganized from a bilaterally symmetric pattern into a highly asymmetric pattern that creates the mature branches of the aortic arch and the pulmonary trunk. Two principal outflow tract malformations, persistent truncus arteriosus (PTA) and double outlet right ventricle (DORV), are of relevance to this study. PTA represents a failure in outflow tract septation, and results in a persisting single outflow tract (in severe cases) or in a single outflow valve apparatus with a variable extent of septation more distally. In DORV, outflow tract septation occurs normally, but the aortic outflow originates abnormally from the right ventricle. By E14.5, all major aspects of cardiac morphogenesis are completed, whether normally or abnormally, and abnormal outflow tract morphogenesis does not compromise embryo viability until after parturition.
The domain of neural crest from the otic vesicle to the third somite is termed the cardiac neural crest. Fate mapping in avian (Kirby and Waldo, 1995) and mouse (Jiang et al., 2000) embryos has indicated that the cardiac neural crest population migrates from the neural tube into the third, fourth, and sixth pharyngeal arches, surrounds the pharyngeal arch arteries, invades between the distal end of the outflow tract of the heart and the pharyngeal endoderm (the subpharyngeal region), and then infiltrates into the outflow tract, ultimately initiating the formation of the septal tissue that divides the ascending aorta and pulmonary trunk. In avian embryos, specific ablation of the cardiac neural crest results in PTA and DORV, as well as in a variety of defects in the reorganization of the pharyngeal arch arteries (Kirby and Waldo, 1995) . In mice, mutation of the Pax3 (Splotch) gene, which is expressed in neural crest cells which later populate pharyngeal arches 3, 4, and 6, causes a similar spectrum of defects (Franz, 1989) . The cardiac neural crest is also involved in the normal morphogenesis of the thymus, thyroid, and parathyroid organs, which develop via the juxtaposition of pharyngeal endoderm and neural crest, and avian cardiac neural crest ablated embryos, as well as mouse Splotch mutants, have defects in these organs, in addition to their cardiac malformations. The human DiGeorge syndrome (Greenberg, 1993) , caused by a microdeletion on chromosome 22, includes defects in the outflow tract, aortic arch arteries, and thymus/thyroid/parathyroid organs, and is presumed to compromise expression of genes which function in the fate of the cardiac neural crest.
AP-2a is clearly expressed in the cardiac neural crest, as well as in the cranial neural crest (Mitchell et al., 1991) , and in fact has been used as a specific marker of the migratory cardiac neural crest population that reaches the outflow tract of the heart (Conway et al., 1997) . While the association between craniofacial defects in AP-2a 2/2 embryos and the normal expression of AP-2a in preotic cranial neural crest is particularly well established, cardiac defects have not previously been described in AP-2a 2/2 embryos. In this study, we document cardiac and aortic arch artery defects in AP-2a-deficient embryos, and utilize a newly derived genetic marker to follow the distribution of AP-2a-expressing cells in the developing heart.
Results

Cardiac outflow tract defects in AP-2a -deficient embryos
We initially analyzed five AP-2a-deficient embryos derived from matings between adult mice heterozygous for the original AP-2a knockout allele (Zhang et al., 1996) , to determine if the absence of AP-2a is causative to structural heart defects. All five embryos had severe cardiac outflow tract malformations (Table 1 and Fig. 1 ), but otherwise appeared mostly normal in ventricular, atrio-ventricular valve, and atrial anatomy. In three embryos, the aortic and pulmonary outflow structures were properly formed, but both originated completely from the right ventricle (i.e. DORV). In a fourth embryo, there was a complete failure to septate the outflow tract, and the persisting single vessel originated from the right ventricle through a single valvular apparatus. This description is classified (van Praagh and van Praagh, 1965) as the A2 subtype of PTA. In the remaining embryo, there was a fused valvular apparatus, but with separated aortic and pulmonary vessels found distally; this is classified as PTA type A1. All five embryos had a membranous ventricular septal defect, which is a hemodynamic necessity of the outflow tract anomalies and is unlikely to reflect an independent problem in ventricular morphogenesis. Three of the five embryos additionally had anomalous aortic arch arteries: two had retroesophageal right subclavian artery, and one had type B interrupted aortic arch. In most embryos (including embryos described below), a thin membrane covering the thoracic cavity was present, such that the heart was located within a pericardial cavity that appeared normal (e.g. Fig. 1e ,g,h,j-l); in other embryos (e.g. Fig. 1f) , there was no membrane covering the thoracic cavity and therefore no pericardial cavity, although in these embryos, the surface of the heart was still lined by epicardium (not shown). The embryos studied for anatomi- (j-l) Three sections from embryo 2, showing PTA-A1. The sections cut through: (j), the aortic outflow tract; (k), the neural crest-derived outflow tract (aorticopulmonary) septum (*); (l), the pulmonary outflow tract. The arrow in panel k indicates a supravalvular space which is common to the aortic and pulmonary channels. Ao, ascending aorta; ct, conotruncal tissue; dAo, dorsal aorta; LV and RV, left and right ventricles; pa, pulmonary arteries; PT, pulmonary trunk; rdAo, right-sided dorsal aorta. Scale is the same for all sections; scale bar in panel a, 500 mm. cal defects were isolated at different stages (two at E14.5, two at E15.5, and one at full term), although this is unlikely to influence the presence or severity of the cardiac defects that were found.
AP-2a heterozygous embryos were normal in all aspects of cardiac development (11 of 11, analyzed histologically; Fig. 1a-d) , and Mendelian numbers of heterozygotes have been raised to adulthood without any apparent manifestation. Thus, while deficiency of AP-2a causes severe heart outflow tract defects, as well as numerous additional deficiencies throughout the embryo, there is no evidence for haploinsufficiency as a contributing parameter to these defects.
Derivation of an AP-2a lacZ knock-in allele
A new mutant allele of AP-2a (designated AP-2a ki7lacZ and abbreviated hereafter as AP-2a ki ) was established in mice by insertion of an IRES-lacZ sequence into exon 7 of the AP-2a gene (Fig. 2a) . The design of this allele is such that the expressed message includes the first six exons of the normal AP-2a gene, as well as the IRESlacZ sequences in the 7th exon. The insertion disrupts the dimerization and DNA binding domains of the AP-2a protein, such that the encoded protein is predicted to be non-functional. The IRES element allows internal translation initiation of the lacZ coding sequence.
Crossing of the AP-2a ki allele to homozygosity resulted in embryos with an identical external appearance to conventional AP-2a homozygotes (Schorle et al., 1996; Zhang et al., 1996; Fig. 2b ). Ten E14.5-15.5 AP-2a ki/ki homozygotes were evaluated for cardiac malformations, and all exhibited outflow tract abnormalities ( Table 1) . Eight of these embryos had DORV; the two remaining embryos had a right ventricular aortic outflow, coupled with either complete atresia or extreme stenosis of the proximal pulmonary outflow tract. These latter two embryos are an extreme variant of DORV, and would more correctly be classified as having tetralogy of Fallot (TOF). The AP2a ki/ki mice also displayed a similar range of aortic arch 2/2 embryos in neural tube closure defects, highly disorganized craniofacial structures, and in the failure of ventral body wall closure. Note the absence of Xgal staining in the heart (h) at this stage.
artery defects as observed with the original knockout allele (Table 1) . As with these cardiac malformations, comparable defects in all other developmental processes were seen in AP-2a ki/ki and conventional AP-2a knockout embryos (e.g. body wall, cranial, etc.), indicating that the AP-2a ki allele is equivalent in effect to the loss-of-function allele described previously. We suspect that the variability in cardiac phenotypes among AP-2a-deficient embryos reflects the mixed strain backgrounds of these mice.
Distribution of the cardiac neural crest in AP-2a -deficient embryos
The design of the AP-2a ki allele allows detection of the lacZ product in cells which are transcribing the AP-2a locus, although AP-2a protein is not made from the derived transcript. Previous in situ hybridization studies (cited above) have demonstrated that the AP-2a gene is expressed in the ectoderm, in migratory cranial and cardiac neural crest, in the progress zone of the developing limb, in the developing kidney, and in the lens. Xgal staining was detected in all of these sites in AP-2a ki/1 embryos (see below, and data not shown), indicating that alteration of the AP-2a transcript by insertion of the IRES-lacZ sequence has no apparent effect on gene transcription.
As the cardiac outflow tract defects of AP-2a-deficient embryos are most likely to be explained by a deficiency in the fate and/or function of the cardiac neural crest, we used Xgal staining to visualize the distribution of AP-2a-expressing cells in littermate AP-2a ki/1 and AP-2a ki/ki embryos. As described below, at all stages examined, the pattern of lacZ expression in AP-2a ki/ki embryos was identical to that of heterozygotes, although the staining intensity was noticeably stronger in the homozygotes. This may simply reflect the presence of two lacZ-expressing alleles relative to one, although it is also possible that the absence of functional AP-2a protein results in an increase in the transcription rate of the AP-2a gene, and/or in an increase in the percentage of cells which express AP-2a.
At E8.5, AP-2a mutant embryos are normal in cardiac morphology, as well as in the organization of all other organ systems (Fig. 3) . At this stage, lacZ staining was observed in surface ectoderm, as well as in presumptive cranial neural crest (derived from the midbrain and prorhombomere A of the anterior hindbrain), but the more caudal pharyngeal arches into which the cardiac neural crest will migrate are not yet formed. There was no staining in the heart or in the outflow tract, although there were ample numbers of labeled mesenchymal cells surrounding the first pharyngeal arch artery in the first arch (data not shown; see also below).
At E9.5 (Fig. 4) , mutant embryos can be recognized externally by the failure of neural tube closure (Fig. 4b) . At this stage, lacZ-positive cells extensively populate the mesenchyme of pharyngeal arches 1-3 (the more caudal arches are only just forming at this stage) in AP-2a ki/1 and AP-2a ki/ki embryos. Expression was also seen in pharyngeal ectoderm, but not in pharyngeal endoderm or in vascular endothelium, as expected from previous studies. AP-2a-expressing mesenchymal cells in embryos of both genotypes surrounded the first and second pharyngeal arch arteries, although these cells did not envelop the dorsal aortae. This pattern is identical to that observed with an independent mouse neural crest lineage marker (Jiang et al., 2000) . Labeled cells, also of presumptive neural crest origin, were seen to be invading between the pharynx and the distal end of the outflow tract in embryos of both genotypes (Fig. 4e,f) , although at this stage, the neural crest has not yet migrated into the extracellular matrix of the outflow tract itself, and no labeled cells were found in this region in embryos of either genotype. An additional population of labeled cells of presumptive third and fourth arch neural crest origin were found more caudally, migrating into the region between the foregut and the pericardial cavity ( ki/ki embryos. AP-2a is expressed in the cranial ectoderm and neural crest, although all segments of the heart are unlabeled. OFT, outflow tract; h, heart; V, ventricle. Scale is the same for all sections; scale bar in panel e, 100 mm.
4g,h). These cells will soon infiltrate into the outflow tract as the relative position of the outflow tract moves caudally; however, in these E9.5 embryos, the third and fourth arch arteries are only just forming and have not yet connected to the distal segment of the outflow tract.
At E10.5 (Fig. 5) , in both normal and AP-2a-deficient embryos, the first and second arch arteries have regressed, the outflow tract has moved caudally relative to the cranium, and the third, fourth, and sixth arch arteries are formed and connect the outflow tract to the dorsal aortae and peripheral circulation. LacZ expression in the first and second arch mesenchyme was noticeably less prominent at this stage relative to 1 day earlier. While one possibility is that the AP-2a-expressing cells are overgrown by cells of another lineage (either through differential proliferation or cell death), a more likely explanation is that expression of AP2a is decreased and ultimately eliminated in this population at this time. Strong labeling was still seen in surface ectoderm of the first and second arches, as well as in more caudal arch ectoderm.
Presumptive migratory neural crest cells were seen at E10.5 within the extracellular matrix of the distal segment of the outflow tract, and an equivalent pattern was seen in heterozygous and homozygous embryos. These cells originate from the neural crest-derived mesenchyme located between the pharynx and the outflow tract, and will be responsible for initiating the formation of the septal tissue that creates the aorta and pulmonary trunk from the single outflow vessel of earlier stages. At both E9.5 and E10.5, cells were properly positioned at the distal end of the outflow tract in embryos of both genotypes. Essentially all of the mesenchymal cells in this region were labeled (Fig.  5g 0 ,h 0 ), although as noted above, the staining intensity per cell was greater in homozygous embryos. The density of mesenchymal cells was also comparable between heterozygous and homozygous embryos, although we cannot determine if there is an increase or decrease in the total number of these presumptive neural crest cells in mutant embryos. The cardiac neural crest, in addition to being responsible ,d) , the second pouch (e,f), and the third pharyngeal arch (g,h). Numbers indicate pharyngeal arches. The double headed arrows in panels c and d approximate the location of the oropharyngeal membrane, anterior to which there is expression in surface ectoderm, and posterior to which there is no expression in pharyngeal endoderm. Note the tight juxtaposition of the distal end of the outflow tract and the pharyngeal endoderm lining the foregut (panels e and f), and of the pericardial cavity and the pharyngeal endoderm (panels g and h), between which the neural crest is beginning to migrate. A, atrium; h, heart; FG, foregut; LV and RV, left and right ventricles; OFT, outflow tract; t, thyroid diverticulum. Scale is the same for all sections; scale bar in panel c, 200 mm.
for outflow septation, is also involved in the normal morphogenesis of the thymus, thyroid, and parathyroids. These organs form from components of the pharyngeal endoderm and surrounding mesenchyme, and previous lineage studies (cited above) in mouse and chick embryos have documented the presence of neural crest cells surrounding the anlage of these organs. In AP-2a-deficient embryos, the thymus forms, although often ending up in severely displaced locations (T.W., unpublished observations). We observed, in both normal and mutant embryos, the presence of labeled cells surrounding the thyroid diverticulum at the ventral midline of the second pharyngeal pouch (Fig. 5c,d) , and adjacent to the lateral sides of the third and fourth pharyngeal pouches (from which the thymus and parathyroids originate; Fig. 5c-h ), comparable in pattern with what has been noted in wild-type embryos in a previous study (Jiang et al., 2000) with a different neural crest marker.
At E11.5 (Fig. 6 ) and thereafter (e.g. Fig. 2b and data not shown), expression of the AP-2a ki allele is curtailed in the outflow tract. Scattered staining was observed in the vicinity of the foregut endoderm, in part surrounding the aortic arch arteries, but there was no staining within or near the outflow tract itself. As noted above, this phenomenon was also observed in the first and second pharyngeal arches at E10.5, and probably reflects the cessation of AP-2a expression in neural crest populations as these cells complete migration, reach their terminal locations, and initiate differentiation. It is clear from other studies (Jiang et al., 2000) that a significant fraction of the outflow tract mesenchyme is derived from the neural crest, but by E11.5, this population either no longer expresses AP-2a, or alternatively represents a subpopulation of neural crest that never expressed AP-2a. Indeed, in situ hybridization studies indicate the absence of AP-2a-positive cells in the outflow tract of wild-type mouse hearts at E11.5 (Conway et al., 1997) . Thus, in summary, during the period of AP-2a expression in the cardiac neural crest (from E9.5 to E10.5 or E11.0), the distribution of labeled cardiac neural crest is identical in embryos which will be phenotypically normal and those, which through the absence of AP-2a function, are destined to have cardiac outflow tract defects.
Discussion
We demonstrate in this study that the normal function of the AP-2a gene, which is expressed in cardiac neural crest, is required for the proper formation of the outflow apparatus of the developing heart. This analysis is consistent with previous phenotypic analyses of AP-2a-deficient embryos, which have documented morphogenic defects in the numerous tissues (or their derivatives) in which the AP-2a gene is prominently expressed. The range of cardiac outflow tract malformations seen as a consequence of AP-2a deficiency suggest a specific disruption of the developmental programs in which cardiac neural crest cells participate during outflow tract morphogenesis.
In this study, we have visualized the cardiac neural crest lineage by virtue of its expression of lacZ from the AP-2a locus. The staining pattern appears to include the majority, if not the entirety, of the neural crest lineage (by comparison with the staining pattern of an independent lacZ marker of the neural crest (Jiang et al., 2000) ), and also encompasses non-neural crest tissues in which the endogenous AP-2a gene is expressed. In the cardiac region of the developing embryo, AP-2a expression appears to be quite specific for the neural crest lineage: even with the more sensitive detection afforded by lacZ staining (relative to previous in situ hybridization studies), there is no evidence for AP-2a expression in the endothelium/endocardium, myocardium, pharyngeal endoderm, or non-neural crest mesenchyme and mesoderm surrounding the outflow tract of the developing heart. From this analysis, we draw several important conclusions relevant to the involvement of AP-2a in cardiac neural crest development and in heart outflow tract morphogenesis. First, by virtue of its restricted expression, AP-2a gene function almost certainly occurs within the neural crest lineage, and not within any of the adjacent tissues that might influence neural crest cell fate or function. Second, AP-2a is not required per se for neural crest cell migration, a process which seems to have occurred normally in the lacZ knock-in homozygous embryos examined in this study. Indeed, a comparison between craniofacial and cardiac defects in the knock-in mice indicates that, in both cases, neural crest cell populations form and migrate to their appropriate locations. With respect to craniofacial development, the current findings support the previous hypothesis (Zhang et al., 1996) that the observed defects occur due to inappropriate function of postmigratory cranial neural crest cells in the absence of AP-2a. A similar mechanism appears to operate in the cardiac crest. In particular, a third conclusion that can be drawn from these studies is that the involvement of AP2a in cardiac morphogenesis almost certainly occurs between E9.5 and E11.0, since expression of AP-2a is extinguished by E11.5. The cardiac function of AP-2a presumably occurs when the neural crest cells are in the subpharyngeal region or just entering the outflow tract, as opposed to deeper within the outflow tract itself.
The principal cardiac phenotype seen in AP-2a-deficient embryos is DORV. DORV is believed to initially involve an altered configuration of the outflow tract at what is known as the looping stage (E9.5-10.5 in the mouse), which resolves with the ascending aorta originating pathologically from the right ventricle, rather than becoming aligned with the left ventricle. Several types of experimental manipulation, affecting different tissues in the developing heart, can cause DORV; the restricted cardiac expression of AP-2a in the neural crest implicates the involvement of this lineage in the etiology of DORV in AP-2a 2/2 embryos. While it is now clear that the proper function of the neural crest is one of many circumstances which are required for normal alignment of the outflow tract, the mechanism by which the neural crest influences this aspect of morphogenesis remains to be elucidated. It has been suggested that neural crest cells might modulate the differentiation of myocardial precursors in the subpharyngeal region (Farrell et al., 2001) , allowing a lengthening of the outflow tract which permits the aortic orifice to migrate laterally and become positioned in the left ventricle. It would appear that the mere presence of neural crest cells in the subpharyngeal region is not sufficient to alleviate the etiology of DORV, as these cells are present in abundance and in the proper place in AP-2a-deficient embryos. Rather, AP-2a is presumably involved in some pathway that causes the neural crest to actively promote outflow tract morphogenesis, whether through regulation of myocardial differentiation or through some alternative mechanism.
In our study, we also recovered a low frequency of PTA, as well as a somewhat higher incidence of aortic arch artery defects. The morphogenic basis of PTA (a failure in formation of the outflow tract septum) is clearly distinct from that of DORV (a failure in the alignment of the outflow tract septum with the ventricles). Since the presence of PTA eliminates the possibility of outflow tract alignment, a reasonable interpretation of our data is that the underlying mechanisms that promote outflow tract alignment fail in all AP-2a mutant mice (i.e. as occurred in 13 of 13 informative embryos), whereas PTA occurs with low frequency (two of 15 embryos). While DORV can arise through multiple causes, including but not limited to those involving neural crest, normal outflow tract septation (the process which fails in PTA) is clearly dependent upon the cardiac neural crest, which initiates formation of the septal tissue which divides the aorta and pulmonary trunk. Similarly, normal reorganization of the pharyngeal arch arteries is also dependent upon the cardiac neural crest, which stabilizes the nascent vessels and becomes essential for their persistence (Waldo et al., 1996) . An insufficient number of neural crest cells, such as occurs following neural crest cell ablation in chick embryos (Kirby and Waldo, 1995) or in the mouse Splotch background (Conway et al., 2000; Epstein et al., 2000) , is one cause of both PTA and of aortic arch artery anomalies. Although all of the AP-2a
2/2 embryos we analyzed appeared to have a normal neural crest cell number and distribution, most of these embryos will go on to properly septate the outflow tract (albeit with a misaligned septum as per the DORV phenotype), and with a normally reorganized aortic arch artery pattern. It is possible that in a low frequency of AP-2a knock-out mice, there are neural crest cell proliferation or migration defects which are responsible for PTA and for aortic arch artery abnormalities. However, it is also clear that outflow tract septation and aortic arch artery reorganization can fail, even when neural crest cell number and migration are normal. For example, in retinoic acid receptor-deficient embryos, which have PTA and arch artery defects with 100% penetrance (Lee et al., 1997) , the neural crest cell lineage migrates around the pharyngeal arch arteries and into the outflow tract normally, but fails to induce formation of the outflow tract septum once resident therein (X.J. and H.M.S., unpublished observations).
In this report, we have focused upon cardiac septation defects, but we note that the cardiac neural crest is also required for the normal formation of the thymus, thyroid, and parathyroids. We observed, in both normal and mutant embryos, the presence of labeled cells adjacent to the pharyngeal endoderm from which these organs derive (Fig. 5) . Due to the major body wall closure defect present in AP-2a knockout mice, we have not extensively studied the formation and/or morphology of the thyroid and parathyroid organs, but a histologically differentiated thymus does form in the mutant mice (T.W., unpublished observations). This indicates that the neural crest lineage in AP-2a mutant embryos is competent to induce formation of the thymus, if not of the thyroid and parathyroids as well. In contrast, the normal presence in mutant embryos of cardiac neural crest cells near the outflow tract is not sufficient to induce normal outflow tract morphogenesis, again suggesting a specific function for AP-2a in this aspect of cardiac development.
In this study, we have demonstrated that AP-2a has a primary role in cardiac outflow tract formation. Recently, heterozygous point mutations in the AP-2b gene that create a dominant negative protein have been identified in human kindreds with Char syndrome (Satoda et al., 2000) . This syndrome includes patent ductus arteriosus (PDA), representing the inappropriate persistence of the left sixth aortic arch artery, which normally closes after birth in response to the onset of respiration and the establishment of postnatal pulmonary circulation. It is possible that the dominant negative AP-2b protein in Char syndrome might have some subtle effect on AP-2a expression or function leading to PDA. However, it is not possible to assess the presence of PDA in AP-2a knock-out mice because they die at birth. Nevertheless, the finding that both AP-2a and AP-2b can be associated with congenital heart defects further illustrates the role of this gene family in cardiac morphogenesis. There is now a growing list of mouse and human genes that can be associated with cardiac outflow tract malformations (Chien, 2000; Sucov, 1998) . For most of these genes, there is little insight into their modes of action during cardiovascular development. A crucial area of future investigation will be to link these multiple genes into hierarchical pathways that control cardiac morphogenesis.
Experimental procedures
Generation of AP-2a knock-in mice
A 3.9 kb XhoI-BamHI fragment containing exons 6 and 7 of the mouse AP-2a gene was subcloned from a previously characterized 129/Sv genomic clone (Zhang et al., 1996) . A 4.5 kb BamHI fragment from plasmid 1056 (gift of Austin Smith), which contains an IRES lacZ neo cassette, was then placed into the BglII site that occurs in the coding region of exon 7. Subsequently, two herpes simplex virus thymidine kinase expression cassettes were placed downstream of the AP-2a sequences to generate the knock-in targeting vector (Fig. 2a) . Following linearization with XhoI, 25 mg of the construct was electroporated into CJ-7 ES cells (gift of Thomas Gridley). G418-resistant colonies were screened for the correct targeting event by PCR analysis. Initially, screening was performed for a homologous recombination event involving genomic DNA and the 3 0 region of the targeting vector using the primer pair neo 3 0 KO (5 0 -AAC GCA CGG GTG TTG GGT CGT TTG TTC G-3 0 ) and Kyko3 (5 0 -GGA GGG GGA GTC TTA CCC AAA CCT TGG-3 0 ). These primers occur within the neo gene and in the genomic sequences downstream from the region of homology, respectively. Four clones were identified based upon the presence of the expected 1.2 kb product in the PCR reaction. Subsequently, the occurrence of a correct homologous recombination event involving the 5 0 end of the targeting vector was confirmed in these four clones by PCR analysis using the primer pair Kenko5 (5 0 -GCA TAG TGC ATC GAG GGA GAT ATT GCC-3 0 ) and Iresup (5 0 -GCT AGA CTA GTC TAG CTA GAG CGG CCC GGG-3 0 ). These primers occur within the genomic sequences upstream from the region of homology and in polylinker sequences immediately upstream of the IRES element, respectively. By karyotyping, three of these ES clones were euploid, and were subsequently injected into C57BL/ 6 blastocysts. Resulting chimeric adult male animals from one of these injections were used to derive heterozygous AP-2a knock-in offspring. The targeted mutation has been maintained through backcrossing with outbred Black Swiss mice (Taconic). Note that the neo gene has subsequently been removed from the knock-in allele through interbreeding with mice containing a CRE gene under the control of bactin (gift of Gail Martin). The gross morphology of the homozygous knock-in mice and the lacZ expression pattern are not altered by removal of the neo cassette (data not shown).
Genotyping of adult and embryonic mice
DNA from embryo tissue and adult tail samples was prepared using the DNeasy tissue kit (Qiagen). Adult mice carrying one copy of the knock-in allele were identified either by PCR analysis, using the primer pair neo 3 0 KO and Kyko3 (see above), or by assaying for b-galactosidase activity on isolated tail biopsies. Tails were fixed in 0.25% glutaraldehyde in phosphate-buffered saline (PBS) for 30 min at 48C, and washed in PBS, followed by staining for b-galactosidase activity by standard procedures (Hogan et al., 1994) . For embryo analysis, homozygous knock-in embryos were identified by their distinctive morphology which phenocopied the original knock-out alleles (Schorle et al., 1996; Zhang et al., 1996) . The presence of the knockin allele in heterozygous embryos was determined using both PCR and b-galactosidase staining protocols (as above).
Detection of b -galactosidase activity in whole-mount and sectioned embryos
Heterozygous AP-2a knock-in lines were mated, and noon of the day of the copulatory plug was considered to be 0.5 days post-coitum (dpc). Embryos taken at E8.5-10.5 were fixed in 0.25% glutaraldehyde in PBS for 30 min at 48C, and washed extensively in PBS, then incubated overnight in X-gal following standard procedures (Hogan et al., 1994) . After post-fixing in 4% paraformaldehyde, embryos were photographed, and subsequently dehydrated and embedded in paraffin for sectioning. Cryostat sections of E11.5 embryos embedded and frozen in OCT were X-gal stained as described previously (Jiang et al., 2000) . Sections were counterstained with eosin and nuclear fast red. The numbers of stained and sectioned embryos examined histologically in this study are as follows: at E8.5, two AP-2a ki/1 and two AP-2a ki/ki ; at E9.5, four and three; at E10.5, five and five; and at E11.5, four and three.
